Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Boston Scientific stock

Learn how to easily invest in Boston Scientific stock.

Boston Scientific Corp is a medical devices business based in the US. Boston Scientific shares (BSX) are listed on the NYSE and all prices are listed in US Dollars. Boston Scientific employs 41,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Boston Scientific

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BSX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Boston Scientific stock price (NYSE: BSX)

Use our graph to track the performance of BSX stocks over time.

Boston Scientific shares at a glance

Information last updated 2022-06-27.
Latest market close$38.01
52-week range$34.98 - $47.50
50-day moving average $40.35
200-day moving average $42.30
Wall St. target price$49.82
PE ratio 71.7359
Dividend yield $0 (0%)
Earnings per share (TTM) $0.53

Buy Boston Scientific shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Boston Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Boston Scientific price performance over time

Historical closes compared with the close of $38.01 from 2022-07-01

1 week (2022-06-24) -0.03%
1 month (2022-06-02) -6.54%
3 months (2022-03-29) N/A
6 months (2021-12-31) -10.52%
1 year (2021-07-02) -13.46%
2 years (2020-07-02) 7.43%
3 years (2019-07-02) 42.69
5 years (2017-06-30) 37.12%

Is Boston Scientific stock undervalued or overvalued?

Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Boston Scientific's P/E ratio

Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Boston Scientific shares trade at around 72x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Boston Scientific's PEG ratio

Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1563. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Boston Scientific's EBITDA

Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.

The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.

Boston Scientific financials

Revenue TTM $12.2 billion
Operating margin TTM 17.47%
Gross profit TTM $8.2 billion
Return on assets TTM 4.2%
Return on equity TTM 4.99%
Profit margin 6.66%
Book value $11.71
Market capitalisation $54.4 billion

TTM: trailing 12 months

Boston Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Boston Scientific's total ESG risk score

Total ESG risk: 29.23

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Boston Scientific's environmental score

Environmental score: 1.51/100

Boston Scientific's social score

Social score: 12.87/100

Boston Scientific's governance score

Governance score: 7.87/100

Boston Scientific's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Boston Scientific Corp was last rated for ESG on: 2019-01-01.

Total ESG score 29.23
Total ESG percentile 56.94
Environmental score 1.51
Social score 12.87
Governance score 7.87
Level of controversy 3

Boston Scientific share dividends

We're not expecting Boston Scientific to pay a dividend over the next 12 months.

Have Boston Scientific's shares ever split?

Boston Scientific's shares were split on a 2:1 basis on 5 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.

Boston Scientific share price volatility

Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $34.98 up to $47.5. A popular way to gauge a stock's volatility is its "beta".

BSX.US volatility(beta: 0.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8172. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).

Boston Scientific overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions

What percentage of Boston Scientific is owned by insiders or institutions?
Currently 0.243% of Boston Scientific shares are held by insiders and 93.111% by institutions.
How many people work for Boston Scientific?
Latest data suggests 41,000 work at Boston Scientific.
When does the fiscal year end for Boston Scientific?
Boston Scientific's fiscal year ends in December.
Where is Boston Scientific based?
Boston Scientific's address is: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234
What is Boston Scientific's ISIN number?
Boston Scientific's international securities identification number is: US1011371077
What is Boston Scientific's CUSIP number?
Boston Scientific's Committee on Uniform Securities Identification Procedures number is: 101137107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site